Overweight and/or ObesityBITE-INCT07592728
Brief Inhibitory Training for Eating - Intervention
A study of Overweight and/or Obesity, run by George Mason University at 1 site in United States.
Trial summary
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Read more about this study
- Who is it for?
- Ages 14 to 17 years
- Conditions the study is for
- Overweight and/or Obesity
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteUnited States
- Study dates
- 1 May 2026to 10 Mar 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- 14-17 years old
- Have overweight or obesity (BMI-z≥85th percentile)
- Have a smartphone
- Can read and speak English
- Interest in improving one's diet.
Who cannot join
- Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks
- Not meeting criteria for atypical anorexia nervosa or bulimia nervosa
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
George Mason University
Fairfax, Virginia, 22030
Tyler Mason
About this study
Official title: Inhibitory Control Training for Adolescents
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training.
Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life.
Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.
In the study, participants will:
Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone
- Conditions
- Overweight and/or Obesity
- Being tested
- Daily inhibitory control training
- Keywords
- obesity, adolescent, nutrition, eating behavior
- Medical subject headings
- Obesity, Feeding Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Daily inhibitory control trainingBehavioural
Children will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks
| Study group | Role | What they receive |
|---|---|---|
| Inhibitory control training | Experimental | Not described Receives: Behavioral: Daily inhibitory control training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Inhibitory control
Go-No/Go Task with food cues
Measured: 1 month
Eating self-regulation
Self-Regulation of Eating Behaviour Questionnaire
Measured: 1 month
Secondary outcomes (2)
Binge-eating symptoms
Eating Pathology Symptom Inventory
Measured: 1 month
Diet Quality
Mini-EAT
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 May 2026
- Study start1 May 2026
- Primary completion10 Feb 2027 (estimated)
- Study completion10 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Overweight and/or ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- George Mason University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tyler B Mason, George Mason University
- Investigators
- Tyler Mason, PhD, Principal investigator, George Mason University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07592728
- Sponsor's protocol ID
- STUDY00001112
- Acronym
- BITE-I
- Status last verified
- Jun 2026
- First submitted
- 6 Apr 2026
- Last updated
- 17 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All IPD collected throughout the trial